Records containing: Netherton Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-06-24Non-interventional Study of Patients With Netherton Syndrome to Characterise the Natural History of Disease
-
CLINICAL_TRIALS study record update · 2026-04-27Defining the Skin and Blood Biomarkers of Ichthyosis
-
CLINICAL_TRIALS study record update · 2026-04-21A Multicenter, Open-label Study of QRX003 Lotion in Participants With Netherton Syndrome
-
CLINICAL_TRIALS study record update · 2026-04-08Phase II Clinical Trial Using Humira in Netherton Syndrome
-
CLINICAL_TRIALS study record update · 2026-03-31A Phase 1/1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single and Multiple Ascending Doses of BCX17725 in Healthy Participants and Multiple Doses of BCX17725 in Participants With Netherton Syndrome
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-16A Multicenter, Randomized, Vehicle-Controlled, Double-Blind, Parallel Comparison Study of QRX003 Lotion in Subjects With Netherton Syndrome
-
CLINICAL_TRIALS study record update · 2026-03-12EvasayilTM : A Placebo-controlled Trial to Evaluate the Efficacy and Safety of Spesolimab in the Treatment of Patients With Netherton Syndrome
-
CLINICAL_TRIALS study record update · 2026-02-05A Randomized, Double-Blind, Vehicle-Controlled, First-in-Human Safety, Tolerability and Proof-of-Concept Study of Topical ATR12-351 in Adults With Netherton Syndrome
-
CLINICAL_TRIALS study record update · 2025-12-23Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton Syndrome
-
CLINICAL_TRIALS study record update · 2025-12-16A Phase I/II, Multicenter, Randomized, Double-blind, Placebo Within-patient Controlled, First-in-human (FIH) Proof of Concept (PoC) Study to Evaluate the Safety and Efficacy of Topically Applied SXR1096 Cream in Patients With Netherton Syndrome (NS)
-
CLINICAL_TRIALS study record update · 2025-12-04Syndrome de Netherton : Aspects Cliniques, Physiopathologiques et Identification de Cibles thérapeutiques
-
CLINICAL_TRIALS study record update · 2025-10-10Non-interventional Study of Patients With Netherton Syndrome to Characterise the Natural History of Disease
-
CLINICAL_TRIALS study record update · 2025-07-20A Single Center, Open Label, Expanded Access Study of QRX003 Lotion in Subjects With Netherton Syndrome
-
CLINICAL_TRIALS study record update · 2025-04-24Defining the Skin and Blood Biomarkers of Ichthyosis
-
CLINICAL_TRIALS study record update · 2025-04-02A Multicenter, Open Label Study of QRX003 Lotion in Subjects With Netherton Syndrome
-
CLINICAL_TRIALS study record update · 2025-01-20A Phase 1b/2, Double-Blind, Placebo-Controlled, Randomized, Parallel-Arm Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome
-
CLINICAL_TRIALS study record update · 2023-08-23A Randomized Double-blinded Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome
-
CLINICAL_TRIALS study record update · 2023-05-18A Phase 1, Subject- and Investigator-Blinded, Sponsor-Unblinded, Placebo-Controlled, Randomized, Sequential Cohort Study to Assess the Safety and Pharmacokinetics of Multiple Ascending Subcutaneous Doses of DS-2325a in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2023-03-06A Phase 1, Subjects- and Investigator-Blinded, Sponsor-Unblinded, Placebo-Controlled, Randomized, Sequential Cohort Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS-2325a in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2021-08-25A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Maintenance Dosing Period to Evaluate the Efficacy and Safety of Secukinumab in Patients With Ichthyoses
-
CLINICAL_TRIALS study record update · 2020-12-08A First-In-human Study to Evaluate Safety and Tolerability of Topical BPR277 in Healthy Volunteers, and Proof of Concept (PoC) Studies to Evaluate the Safety, Tolerability, and Efficacy of Topical BPR277 in Patients With Atopic Dermatitis and Netherton Syndrome
-
CLINICAL_TRIALS study record update · 2016-10-19Phase I Study of Ex-vivo Lentiviral Gene Therapy for the Inherited Skin Disease Netherton Syndrome
-
CLINICAL_TRIALS study record update · 2014-12-12Exploratory Safety and Systemic Absorption of Elidel (Pimecrolimus) 1% Cream for the Treatment of Netherton Syndrome